Alpha Modus Holdings, Inc. engages in creating, developing, and licensing data driven technologies to enhance consumers in-store digital experience at the point of decision in the United States. The ...
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback